Pharmaceutical Industry
Page 19 of 100
FinanceWall Street is now betting against restaurant stocks because of Novo Nordisk’s Ozempic and high interest rates
By Prarthana PrakashOctober 10, 2023
Health‘These pharmacists always look stressed’: Drugstores struggle with thin staffing and recruiting challenges as busiest season begins
By Tom Murphy and The Associated PressOctober 7, 2023
LifestyleWeight-loss-aiding drugs Ozempic and Wegovy are dampening food sales, top Walmart exec says
By Chloe TaylorOctober 5, 2023
FinanceDrugs aiding weight-loss like Ozempic have so much promise, a major bank is telling investors to short junk-food credit
By Prarthana PrakashOctober 4, 2023
HealthOzempic and Wegovy ‘significantly’ improve blood sugar and weight for the long-term, new study suggests
By Erin PraterOctober 2, 2023
SuccessCVS is promising to boost hiring after overworked pharmacists don’t show up, but longterm solution to worker shortage is elusive
By Josh Funk and The Associated PressSeptember 28, 2023
By Howard DeanSeptember 19, 2023
RetailWegovy maker Novo Nordisk leapfrogs LVMH to become Europe’s most valuable company after it takes its ‘miracle’ weight loss drug to the U.K.
By Prarthana PrakashSeptember 5, 2023
CommentarySmoke and mirrors: I’ve been debating Vivek Ramaswamy for 2 years. Here’s how I got past his diversionary tactics
By Jeffrey SonnenfeldAugust 31, 2023
CommentaryU.S. health care has been in crisis since Nixon–but two economists may have found a way to radically disrupt it
By John G. SingerAugust 10, 2023
HealthPopular weight-loss injectable Wegovy cuts risk of heart attack and stroke by 20%, company says
By Erin PraterAugust 8, 2023
MagazineNovo Nordisk developed Ozempic and started a weight-loss revolution. Its next moonshot is eliminating obesity altogether
By Vivienne WaltJuly 31, 2023
HealthOzempic manufacturer Novo Nordisk spent $11 million last year ‘wining and dining’ doctors. Experts slam the move as a breach of doctor-patient trust
By Erin PraterJuly 21, 2023
Most Popular
